Neovasc Announces Second Quarter 2018 Financial Results Conference Call and Webcast
02 August 2018 - 9:30PM
PR Newswire (Canada)
NASDAQ, TSX: NVCN
VANCOUVER, Aug. 2, 2018 /CNW/ - Neovasc, Inc. ("Neovasc" or
the "Company") (NASDAQ:NVCN)(TSX: NVCN), a leader in the
development of minimally invasive transcatheter mitral valve
replacement technologies, today announced that it will report
financial results for the quarter and six months ended June 30, 2018 and host a conference call and
webcast at 4:30pm Eastern Time on
Wednesday, August 8, 2018.
Conference Call
& Webcast
|
|
Wednesday, August
8th @ 4:30pm Eastern Time
|
|
Domestic:
|
888-254-3590
|
International:
|
323-994-2093
|
Passcode:
|
9226007
|
Webcast:
|
http://public.viavid.com/index.php?id=130206
|
|
|
Replays available
through August 22nd:
|
|
Domestic:
|
844-512-2921
|
International:
|
412-317-6671
|
Conference
ID:
|
9226007
|
About Neovasc Inc.
Neovasc is a specialty medical
device company that develops, manufactures and markets products for
the rapidly growing cardiovascular marketplace. Its products
include the Neovasc Reducer™ (the "Reducer"), for the treatment of
refractory angina, which is not currently commercially available in
the United States and has been
commercially available in Europe
since 2015, and the Tiara™ (the "Tiara"), for the transcatheter
treatment of mitral valve disease, which is currently under
clinical investigation in the United
States , Canada and
Europe . For more information,
visit: www.neovasc.com.
SOURCE Neovasc Inc.
Copyright 2018 Canada NewsWire
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Jul 2023 to Jul 2024